Status:
COMPLETED
Lung Cancer Registry for Lung Cancer Patients
Lead Sponsor:
Oncology Center of Biochemical Education And Research
Collaborating Sponsors:
Bristol-Myers Squibb
Conditions:
Lung Cancer
Eligibility:
All Genders
18+ years
Brief Summary
In the light of a new era in the management of lung cancer this non-interventional study intend to capture all the epidemiological, clinical, pathological, molecular and treatment parameters of non-sm...
Detailed Description
Investigators intend to build an electronic database which will record the epidemiological, clinical, pathological, molecular data and treatment parameters of lung cancer patients (NSCLC and SCLC) who...
Eligibility Criteria
Inclusion
- \- Since this will be a non-interventional study all adult patients who will be consent for registration of their data to EDB will be enrolled.
Exclusion
- Patients with insufficient epidemiological or clinical data will be excluded such as patients with no demographic data or patients that have not taken at least 2 cycles of therapy.
Key Trial Info
Start Date :
August 8 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 27 2018
Estimated Enrollment :
650 Patients enrolled
Trial Details
Trial ID
NCT03276429
Start Date
August 8 2017
End Date
December 27 2018
Last Update
March 14 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
OCEBER
Athens, Greece, 11527